Related Experiment Video

Updated: Aug 10, 2026

GABA-activated Single-channel and Tonic Currents in Rat Brain Slices
09:59

GABA-activated Single-channel and Tonic Currents in Rat Brain Slices

Published on: July 17, 2011

Ketamine decreases the open time of single-channel currents activated by acetylcholine

R E Wachtel1

  • 1Veterans Administration Medical Center, Iowa City, Iowa.

Anesthesiology
|April 1, 1988
PubMed

Insights

Ketamine reduces the open time of acetylcholine-activated channels in muscle cells. This effect, observed at clinical doses, may explain ketamine

Area of Science:

  • Neuropharmacology
  • Molecular Neuroscience
  • Ion Channel Physiology

Background:

  • Ketamine is an anesthetic with complex neurological effects.
  • Understanding ketamine's mechanism at the molecular level is crucial.
  • Acetylcholine receptors are key targets in neuromuscular function.

Purpose of the Study:

  • To investigate the direct effects of ketamine on acetylcholine-activated ion channels.
  • To determine the dose-dependency and mechanism of ketamine's action on channel kinetics.
  • To explore the implications of these findings for ketamine's clinical effects.

Main Methods:

  • Utilized patch clamp electrophysiology on BC3H1 mouse tumor cells.
  • Examined single-channel currents activated by acetylcholine.
  • Analyzed channel open-state dwell times and ketamine's impact.

Main Results:

  • Ketamine significantly decreased the average open lifetime of acetylcholine-activated channels.
  • The reduction in channel lifetime was dose-dependent.
  • At clinically relevant concentrations (3 microM), channel lifetime was reduced by approximately 17%.

Conclusions:

  • Ketamine's interaction with ion channels may not follow a simple blocking model.
  • The observed effects on channel kinetics could explain ketamine's potentiation of neuromuscular blocking agents.
  • Similar mechanisms in the central nervous system might contribute to ketamine's overall clinical profile.

More Related Videos

One-channel Cell-attached Patch-clamp Recording13:07

One-channel Cell-attached Patch-clamp Recording

Published on: June 9, 2014

A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons10:32

A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons

Published on: November 7, 2014

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...